Strana 1 z 86 Výsledek
The invention relates to the subject matter characterized in the claims.
Numerous compounds of general Formula I according to claim 1 have been known heretofore. Thus, U.S. Pat. No. 4,012,495, for example, describes pyrrolidone derivatives of general Formula I, and U.S. Pat. No. 4,186,129 discloses
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to the treatment of indolent dermal irritations. More specifically, it concerns treatment of persistent inflammations such as chemical ulcers, herpes ulcers, radiation burns, psoriasis and sunburn.
2. General Background of
This invention relates to the discovery that a certain beeswax fraction affords an effective topical treatment for certain inflammatory skin conditions.
Beeswax is the yellow or white (bleached) wax obtained from the honeycomb of the bee and consists largely of myricyl palmitate, cerotic acid and
DETAILED DESCRIPTION OF THE INVENTION
Acetylsalicylic acid has been used with increasing frequency and amounts over the past 75 years for the treatment of pains and inflammations. It is an inexpensive, yet highly effective drug. Unfortunately, it has a side effect that makes its oral use dangerous
Anti-inflammatories are widely used for the treatment of inflammations associated with rheumatism and similar disease which are very often chronic in nature. In these instances, treatment with anti-inflammatory compositions is required to be continued for prolonged periods of time, often on a
This invention relates to novel hydrocarbons and ethers and in particular to hydrocarbons and ethers having valuable therapeutic properties.
According to the invention there is provided a compound of formula I ##STR1## in which n = 0 or 1; X is an alkyl or alkenyl group of 2 to 6 carbon atoms, and
FIELD OF THE INVENTION
The present invention relates to compounds which include a carbon chain of 14 to 26 carbon atoms and a nitro or sulphur group. In a particular embodiment the invention relates to nitro analogues of polyunsaturated fatty acids. The present invention further relates to the use
The present invention is concerned with new 5-oxo-2-pyrroline-3-carbonitriles, with the preparation thereof and with pharmaceutical compositions containing them.
The new 5-oxo-2-pyrroline-3-carbonitriles according to the present invention are compounds of the general formula: ##STR3## wherein
The present invention is concerned with new 5-oxo-2-pyrroline-3-carbonitriles, with the preparation thereof and with pharmaceutical compositions containing them.
The new 5-oxo-2-pyrroline-3-carbonitriles according to the present invention are compounds of the general formula: ##STR3## wherein
RELATED APPLICATION
This application is a national stage filing under 35 U.S.C. .sctn.371 of international application PCT/JP2011/070436, filed Sep. 8, 2011, the disclosure of which is incorporated by reference herein in its entirety.
TECHNICAL FIELD
The present invention relates to a probiotic(s)
The invention relates to novel furans, especially benzofuranones of the general formula ##STR2## in which R.sub.1 represents hydrogen or an aliphatic radical, R.sub.2 represents an amino group di-substituted by a divalent hydrocarbon radical, and the aromatic ring A may be additionally substituted,
DESCRIPTION
Technical Field
The present invention relates to novel, pharmacologically active compounds, a process for their preparation including the separation of the obtained stereoisomeric mixture into its separate components (diastereoisomers). The invention also relates to pharmaceutical
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention generally relates to compounds having anti-inflammatory, anti-proliferative and analgesic activity and methods for using these compounds to reduce inflammation, cell proliferation and pain in mammals. Specifically, the
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention generally relates to compounds having anti-inflammatory, anti-proliferative and analgesic activity and methods for using these compounds to reduce inflammation, cell proliferation and pain in mammals.
Specifically, the
BACKGROUND OF THE INVENTION
This invention relates to novel, pharmacologically effective pyridine derivatives, a process for the preparation thereof, pharmaceutical preparations containing these compounds and a method of treating inflammation therewith.
SUMMARY OF THE INVENTION
The compounds of this